Coagulation Factors
8 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Falcon M
Scoop.it!

Preclinical Data From Biogen Idec-Amunix Partnership Presented at ISTH ... - SYS-CON Media (press release)

Preclinical Data From Biogen Idec-Amunix Partnership Presented at ISTH ... - SYS-CON Media (press release) | Coagulation Factors | Scoop.it
Preclinical Data From Biogen Idec-Amunix Partnership Presented at ISTH ...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

Cangene Reports Third Quarter 2013 Results - PharmaLive (press release) (subscription)

Cangene Reports Third Quarter 2013 Results - PharmaLive (press release) (subscription) | Coagulation Factors | Scoop.it
Cangene Reports Third Quarter 2013 Results PharmaLive (press release) (subscription) Completed acquisition of a late-stage Factor IX product known as IB1001, as well as two product candidates in preclinical development, IB1007 (a recombinant FVIIa)...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

Biogen Idec Showcases Commitment to Advancing Hemophilia Treatment and ... - DailyFinance

Biogen Idec Showcases Commitment to Advancing Hemophilia Treatment and ... - DailyFinance | Coagulation Factors | Scoop.it
Biogen Idec Showcases Commitment to Advancing Hemophilia Treatment and ...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

Research and Markets: Recombinant Coagulation Factors 2013 - The Race to Market and for Market Shares: A Technology & Pipeline Assessment and Corporate Benchmarking Analysis | Business Wire

Research and Markets: Recombinant Coagulation Factors 2013 - The Race to Market and for Market Shares: A Technology & Pipeline Assessment and Corporate Benchmarking Analysis | Business Wire | Coagulation Factors | Scoop.it
Research and Markets (http://www.researchandmarkets.com/research/4swgbs/recombinant) has announced the addition of the "Recombinant Coagulation F (Research and Markets: Recombinant Coagulation Factors 2013 - The Race to Market and for Market...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study ... - Canada NewsWire (press release)

CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study ...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

FDA Approves Baxter's RIXUBIS as First Recombinant Factor IX Treatment for ... - MarketWatch (press release)

FDA Approves Baxter's RIXUBIS as First Recombinant Factor IX Treatment for ...
more...
No comment yet.
Scooped by Falcon M
Scoop.it!

Studies will feature research on novel investigational recombinant factor VIIa ... - PR Newswire (press release)

Studies will feature research on novel investigational recombinant factor VIIa ... - PR Newswire (press release) | Coagulation Factors | Scoop.it
Studies will feature research on novel investigational recombinant factor VIIa ...
more...
No comment yet.